Jin Dao Ming - Net Worth and Insider Trading

Jin Dao Ming Net Worth

The estimated net worth of Jin Dao Ming is at least $0 dollars as of 2024-06-24. Jin Dao Ming is the Directors, executives of Youngy Health Co Ltd and owns about 0 shares of Youngy Health Co Ltd (SZSE:300247) stock worth over $0. Details can be seen in Jin Dao Ming's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jin Dao Ming has not made any transactions after 2014-10-29 and currently still holds the listed stock(s).

Transaction Summary of Jin Dao Ming

Jin Dao Ming Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jin Dao Ming owns 1 companies in total, including Youngy Health Co Ltd (SZSE:300247) .

Click here to see the complete history of Jin Dao Ming’s form 4 insider trades.

Insider Ownership Summary of Jin Dao Ming

Ticker	Comapny	Transaction Date	Type of Owner
SZSE:300247	Youngy Health Co Ltd	2014-10-29	Directors & executives

Jin Dao Ming Latest Holdings Summary

Jin Dao Ming currently owns a total of 1 stock. Jin Dao Ming owns 0 shares of Youngy Health Co Ltd (SZSE:300247) as of October 29, 2014, with a value of $0.

Latest Holdings of Jin Dao Ming

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
SZSE:300247	Youngy Health Co Ltd	2014-10-29	0	2.45	0

Holding Weightings of Jin Dao Ming

Jin Dao Ming Form 4 Trading Tracker

According to the SEC Form 4 filings, Jin Dao Ming has made a total of 0 transactions in Youngy Health Co Ltd (SZSE:300247) over the past 5 years. The most-recent trade in Youngy Health Co Ltd is the sale of 5,000,000 shares on October 29, 2014, which brought Jin Dao Ming around $51 Million.

Insider Trading History of Jin Dao Ming

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jin Dao Ming Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jin Dao Ming Ownership Network

Ownership Network List of Jin Dao Ming

No Data

Ownership Network Relation of Jin Dao Ming

Jin Dao Ming Owned Company Details

What does Youngy Health Co Ltd do?

Who are the key executives at Youngy Health Co Ltd?

Jin Dao Ming is the Directors & executives of Youngy Health Co Ltd. Other key executives at Youngy Health Co Ltd include Secretary Dong Liang Jun , Securities Affairs Representative Zhang Wei Xin , and Directors & executives Wang Yan .

Youngy Health Co Ltd (SZSE:300247) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Youngy Health Co Ltd (SZSE:300247) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Youngy Health Co Ltd (SZSE:300247) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Youngy Health Co Ltd (SZSE:300247)'s detailed insider trading history can be found in Insider Trading Tracker table.

Youngy Health Co Ltd Insider Transactions

No Available Data

Jin Dao Ming Mailing Address

Above is the net worth, insider trading, and ownership report for Jin Dao Ming. Currently GuruFocus does not have mailing address information for Jin Dao Ming.

Discussions on Jin Dao Ming

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.